551 related articles for article (PubMed ID: 32669424)
1. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance.
Akkari L; Bowman RL; Tessier J; Klemm F; Handgraaf SM; de Groot M; Quail DF; Tillard L; Gadiot J; Huse JT; Brandsma D; Westerga J; Watts C; Joyce JA
Sci Transl Med; 2020 Jul; 12(552):. PubMed ID: 32669424
[TBL] [Abstract][Full Text] [Related]
2. CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Pyonteck SM; Akkari L; Schuhmacher AJ; Bowman RL; Sevenich L; Quail DF; Olson OC; Quick ML; Huse JT; Teijeiro V; Setty M; Leslie CS; Oei Y; Pedraza A; Zhang J; Brennan CW; Sutton JC; Holland EC; Daniel D; Joyce JA
Nat Med; 2013 Oct; 19(10):1264-72. PubMed ID: 24056773
[TBL] [Abstract][Full Text] [Related]
3. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.
Quail DF; Bowman RL; Akkari L; Quick ML; Schuhmacher AJ; Huse JT; Holland EC; Sutton JC; Joyce JA
Science; 2016 May; 352(6288):aad3018. PubMed ID: 27199435
[TBL] [Abstract][Full Text] [Related]
4. Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.
Stafford JH; Hirai T; Deng L; Chernikova SB; Urata K; West BL; Brown JM
Neuro Oncol; 2016 Jun; 18(6):797-806. PubMed ID: 26538619
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
6. The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2.
Berg TJ; Marques C; Pantazopoulou V; Johansson E; von Stedingk K; Lindgren D; Jeannot P; Pietras EJ; Bergström T; Swartling FJ; Governa V; Bengzon J; Belting M; Axelson H; Squatrito M; Pietras A
Cancer Res; 2021 Apr; 81(8):2101-2115. PubMed ID: 33483373
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.
Yan D; Kowal J; Akkari L; Schuhmacher AJ; Huse JT; West BL; Joyce JA
Oncogene; 2017 Oct; 36(43):6049-6058. PubMed ID: 28759044
[TBL] [Abstract][Full Text] [Related]
8. The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma.
Zhang L; Jiang Y; Zhang G; Wei S
Front Immunol; 2023; 14():1238233. PubMed ID: 37731483
[TBL] [Abstract][Full Text] [Related]
9. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
11. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
12. Distinct spatiotemporal features of microglia and monocyte-derived macrophages in glioma.
Banerjee K; Ratzabi A; Caspit IM; Ganon O; Blinder P; Jung S; Stein R
Eur J Immunol; 2023 Apr; 53(4):e2250161. PubMed ID: 36649079
[TBL] [Abstract][Full Text] [Related]
13. Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages.
Chen Z; Ross JL; Hambardzumyan D
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14254-14259. PubMed ID: 31235603
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
Crotty EE; Smith SMC; Brasel K; Pakiam F; Girard EJ; Connor YD; Zindy F; Mhyre AJ; Roussel MF; Olson JM
J Neurooncol; 2021 Jun; 153(2):225-237. PubMed ID: 33963961
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth.
Ji J; Ding K; Cheng B; Zhang X; Luo T; Huang B; Yu H; Chen Y; Xu X; Lin H; Zhou J; Wang T; Jin M; Liu A; Yan D; Liu F; Wang C; Chen J; Yan F; Wang L; Zhang J; Yan S; Wang J; Li X; Chen G
Adv Sci (Weinh); 2024 Apr; 11(15):e2304609. PubMed ID: 38342629
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma.
Almahariq MF; Quinn TJ; Kesarwani P; Kant S; Miller CR; Chinnaiyan P
In Vivo; 2021; 35(1):119-129. PubMed ID: 33402457
[TBL] [Abstract][Full Text] [Related]
17. [Malignant gliomas--radiotherapy].
Schratter-Sehn A
Wien Med Wochenschr; 2006 Jun; 156(11-12):342-5. PubMed ID: 16944365
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages.
Choi J; Stradmann-Bellinghausen B; Yakubov E; Savaskan NE; Régnier-Vigouroux A
Cancer Biol Ther; 2015; 16(8):1205-13. PubMed ID: 26047211
[TBL] [Abstract][Full Text] [Related]
19. Expression of enzymes and oncogene induced after radiotherapy and/or chemotherapy in patients with brain tumors.
Yoshii Y; Saito A; Hyodo A; Tsurushima H; Sun L
Hum Cell; 2001 Mar; 14(1):95-103. PubMed ID: 11436358
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
Fine HA; Figg WD; Jaeckle K; Wen PY; Kyritsis AP; Loeffler JS; Levin VA; Black PM; Kaplan R; Pluda JM; Yung WK
J Clin Oncol; 2000 Feb; 18(4):708-15. PubMed ID: 10673511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
